{"id":13409,"date":"2020-04-07T15:04:58","date_gmt":"2020-04-07T15:04:58","guid":{"rendered":"https:\/\/ebrandservices.fr\/?p=13409"},"modified":"2025-04-28T13:12:55","modified_gmt":"2025-04-28T13:12:55","slug":"covid-19-la-contrefacon-cible-les-produits-pharmaceutiques","status":"publish","type":"post","link":"https:\/\/ebrand.com\/fr\/blog\/covid-19-la-contrefacon-cible-les-produits-pharmaceutiques\/","title":{"rendered":"L\u2019IMPACT DU COVID-19 : LA CONTREFA\u00c7ON"},"content":{"rendered":"<h2 style=\"font-size: 32px;\"><strong>Foin des mesures de quarantaine\u00a0! Les pirates s\u2019adaptent et sont l\u00e0, toujours plus actifs. Le Covid-19 leur permet de surfer sur la vague d\u2019anxi\u00e9t\u00e9 qui s\u2019empare des consommateurs en irriguant la toile de produits pharmaceutiques contrefaits et potentiellement dangereux. Les chiffres d\u00e9j\u00e0 alarmants r\u00e9v\u00e9l\u00e9s par la r\u00e9cente \u00e9tude men\u00e9e par l\u2019OCDE et l\u2019EUIPO risquent d\u2019\u00eatre largement d\u00e9pass\u00e9s. <\/strong><\/h2>\n<h2><strong>DU CORONAVIRUS A LA \u00ab\u00a0CORONA-MAFIA\u00a0\u00bb<\/strong><\/h2>\n<p><em>\u00ab\u00a0Les organisations criminelles sont comme la Bourse, elles anticipent toujours les directions\u00a0\u00bb,<\/em> \u00e9crit Roberto Saviano le 22 mars dernier dans \u00ab<a href=\"https:\/\/www.repubblica.it\/cronaca\/2020\/03\/23\/news\/la_mafia_del_virus_dalla_droga_alla_sanita_la_pandemia_aiuta_l_economia_criminale-252023708\/?ref=search\">\u00a0la Repubblica\u00a0<\/a>\u00bb. Plus loin, le journaliste et \u00e9crivain italien, auteur de <em>\u00ab\u00a0Gomorra\u00a0\u00bb<\/em>, un livre remarqu\u00e9 sur la mafia napolitaine, connue sous le nom de Camorra, explique. <em>\u00ab La pand\u00e9mie est le moment id\u00e9al pour les mafias et la raison est simple : si vous avez faim, vous cherchez du pain, peu importe de quel four il provient et qui le distribue ; si vous avez besoin d\u2019un m\u00e9dicament, vous payez, vous ne vous demandez pas qui vous le vend, vous le voulez. Ce n\u2019est qu\u2019en temps de paix et de bien-\u00eatre que le choix est possible\u2009\u00bb. \u00a0<\/em>\u00a0<\/p>\n<h2><strong>2 500 LIENS SUPPRIMES SUR INTERNET ET 13 MILLIONS D\u2019EUROS DE PRODUITS SAISIS <\/strong><\/h2>\n<p>C\u2019est un fait, il a suffi d\u2019un virus et de la peur qu\u2019il a suscit\u00e9e pour que les fraudes se propagent \u00e0 la m\u00eame vitesse que lui. Une preuve\u00a0? La derni\u00e8re op\u00e9ration <a href=\"https:\/\/www.interpol.int\/fr\/Actualites-et-evenements\/Actualites\/2020\/Une-operation-mondiale-met-au-jour-une-augmentation-des-faux-produits-medicaux-dans-le-contexte-de-la-COVID-19\">PANGEA<\/a>, coordonn\u00e9e par INTERPOL dans plus de 90 pays entre les 3 et 10 mars 2020 s\u2019est traduite par\u00a0:<\/p>\n<ul>\n<li>121 arrestations ;<\/li>\n<li>13 millions d&rsquo;euros de produits pharmaceutiques <strong>potentiellement dangereux<\/strong> saisis ;<\/li>\n<li>326 00 colis inspect\u00e9s ;<\/li>\n<li>48 000 colis saisis ;<\/li>\n<li>4,4 millions d&rsquo;unit\u00e9s de <strong>produits pharmaceutiques illicites<\/strong> saisies dans le monde entier ;<\/li>\n<li><strong>37 000 dispositifs m\u00e9dicaux non autoris\u00e9s et contrefaits saisis<\/strong> (principalement des masques chirurgicaux et des kits d&rsquo;autotest pour la surveillance du VIH et du glucose) ;<\/li>\n<li>37 groupes de crime organis\u00e9 d\u00e9mantel\u00e9s\u00a0;<\/li>\n<li>2 500 liens supprim\u00e9s, notamment sur les sites web, m\u00e9dias sociaux, places de march\u00e9 en ligne, publicit\u00e9s.<\/li>\n<\/ul>\n<p>Les r\u00e9sultats de l&rsquo;op\u00e9ration r\u00e9v\u00e8lent aussi une augmentation inqui\u00e9tante des m\u00e9dicaments antiviraux non autoris\u00e9s et notamment <strong>un bond de plus de 100 % des saisies de chloroquine<\/strong> par rapport \u00e0 la m\u00eame op\u00e9ration r\u00e9alis\u00e9e en 2018.\u00a0<\/p>\n<h2><strong>1 \u20ac LE CACHET D&rsquo;HYDROXYCHLOROQUINE<\/strong><\/h2>\n<p>L&rsquo;hydroxychloroquine encore\u00a0! Le 31 mars, le travail men\u00e9 par la Section de recherches de Strasbourg conduit \u00e0 la <strong>fermeture de 70 sites et blogs de vente illicite<\/strong> (jusqu\u2019\u00e0 <em>\u00ab\u00a0un euro le cachet\u00a0\u00bb<\/em>, contre 4 euros environ la bo\u00eete de 30 en pharmacie) de ce produit fort recherch\u00e9. Les enqu\u00eateurs ont pu d\u00e9nombrer <strong>plus de 43\u00a0000 visiteurs<\/strong> sur ces sites, notamment en provenance de France et d\u2019Italie, entre le 1<sup>er<\/sup> et le 29 mars, selon Pablo Agnan, de \u00ab\u00a0<a href=\"https:\/\/www.gendinfo.fr\/enquetes\/2020\/chloroquine-un-trafic-en-pleine-expansion?fbclid=IwAR2Ia9H19IlLfipoQYQkpixoao6hLWd_yeWCZ4aYHNsj5EpYgJr1X8Y91pE\">GENDinfo<\/a>\u00a0\u00bb.<\/p>\n<p>Si la crise actuelle aggrave consid\u00e9rablement le ph\u00e9nom\u00e8ne, elle ne l\u2019a pourtant pas d\u00e9clench\u00e9. Le rapport publi\u00e9 conjointement par l\u2019OCDE et l\u2019EUIPO le 23 mars 2020 estime en effet la valeur totale des produits pharmaceutiques de contrefa\u00e7on commercialis\u00e9s dans le monde \u00e0 <strong>4,03 milliards d\u2019euros<\/strong>. Une somme probablement sous-\u00e9valu\u00e9e puisque selon l\u2019EUIPO, <em>\u00ab\u00a0les conclusions du rapport ne couvrent pas les produits pharmaceutiques de contrefa\u00e7on fabriqu\u00e9s et consomm\u00e9s sur les territoires nationaux et au sein de l\u2019Union europ\u00e9enne.\u00a0\u00bb<\/em><\/p>\n<p>\u00c0 juste titre, la <a href=\"https:\/\/www.economie.gouv.fr\/dgccrf\/arnaques-liees-au-coronavirus\">Direction g\u00e9n\u00e9rale de la Concurrence, de la Consommation et de la R\u00e9pression des fraudes (DGCCRF)<\/a> rappelle\u00a0notamment sur son site <strong>qu\u2019il n\u2019existe pas \u00e0 ce jour de vaccin<\/strong>, <strong>que les d\u00e9pistages du Coronavirus sont uniquement effectu\u00e9s par les autorit\u00e9s sanitaires<\/strong>, <strong>que des sites internet frauduleux cherchent \u00e0 vendre des m\u00e9dicaments<\/strong> all\u00e9guant une efficacit\u00e9 contre le virus\u2026alors que la vente de ces derniers n\u2019est possible que sur prescription m\u00e9dicale et en pharmacie.\u00a0<\/p>\n<h2><strong>Conterfaits: Conseil d\u2019expert<\/strong><\/h2>\n<p>D\u00e9j\u00e0, <a href=\"https:\/\/ebrandservices.fr\/faux-medicaments-quand-vigilance-rime-avec-surveillance\/\">dans notre article du 1<sup>er<\/sup> f\u00e9vrier sur la contrefa\u00e7on de m\u00e9dicaments<\/a>,\u00a0nous relevions que <strong>ce trafic mortif\u00e8re rapportait probablement 20 fois plus que l\u2019h\u00e9ro\u00efne<\/strong> et faisions \u00e9tat des chiffres suivants\u00a0:<\/p>\n<ul>\n<li>1 million de d\u00e9c\u00e8s annuels dans le monde dus directement ou indirectement \u00e0 l\u2019absorption de m\u00e9dicaments falsifi\u00e9s ou contrefaits (chiffres OMS 2013),<\/li>\n<li>10,2 milliards d\u2019euros perdus chaque ann\u00e9e rien que dans l\u2019UE.<\/li>\n<\/ul>\n<p>Dans le contexte actuel de pand\u00e9mie, il est devenu <strong>indispensable pour les autorit\u00e9s comme les industriels des secteurs pharmaceutique et parapharmaceutique de surveiller ce qui se passe sur les places de march\u00e9 en ligne, les r\u00e9seaux sociaux, les sites Web et les noms de domaine<\/strong>. Ces surveillances permettent de d\u00e9tecter et supprimer les infractions mais aussi de collecter un certain nombre d\u2019informations qui, recrois\u00e9es, peuvent justifier et d\u00e9clencher une enqu\u00eate.<\/p>\n<p><strong>Rappelons qu\u2019en cette p\u00e9riode de confinement, <a href=\"https:\/\/ebrand.com\/fr\/protection-de-la-marque-en-ligne\/\">EBRAND se met \u00e0 la disposition des autorit\u00e9s et des industriels des secteurs concern\u00e9s<\/a>.<\/strong><\/p>\n<p><em>Par Rapha\u00ebl TESSIER &amp; Sophie AUDOUSSET pour EBRAND France.\u00a0<\/em><\/p>\n\n\n<p class=\"wp-block-paragraph\"><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Foin des mesures de quarantaine\u00a0! Les pirates s\u2019adaptent et sont l\u00e0, toujours plus actifs. Le Covid-19 leur permet de surfer sur la vague d\u2019anxi\u00e9t\u00e9 qui s\u2019empare des consommateurs en irriguant la toile de produits pharmaceutiques contrefaits et potentiellement dangereux. Les chiffres d\u00e9j\u00e0 alarmants r\u00e9v\u00e9l\u00e9s par la r\u00e9cente \u00e9tude men\u00e9e par l\u2019OCDE et l\u2019EUIPO risquent d\u2019\u00eatre [&hellip;]<\/p>\n","protected":false},"author":8,"featured_media":42719,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[900,901],"tags":[],"class_list":["post-13409","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-contrefacon","category-places-de-marche"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v28.0 (Yoast SEO v28.1) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>L\u2019IMPACT DU COVID-19 : LA CONTREFA\u00c7ON - EBRAND<\/title>\n<meta name=\"description\" content=\"Explorez comment les pirates profitent du Covid-19 pour diffuser des produits pharmaceutiques contrefaits, selon l&#039;OCDE et l&#039;EUIPO.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ebrand.com\/fr\/blog\/covid-19-la-contrefacon-cible-les-produits-pharmaceutiques\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"L\u2019IMPACT DU COVID-19 : LA CONTREFA\u00c7ON\" \/>\n<meta property=\"og:description\" content=\"Explorez comment les pirates profitent du Covid-19 pour diffuser des produits pharmaceutiques contrefaits, selon l&#039;OCDE et l&#039;EUIPO.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ebrand.com\/fr\/blog\/covid-19-la-contrefacon-cible-les-produits-pharmaceutiques\/\" \/>\n<meta property=\"og:site_name\" content=\"EBRAND\" \/>\n<meta property=\"article:published_time\" content=\"2020-04-07T15:04:58+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-04-28T13:12:55+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ebrand.com\/wp-content\/uploads\/2020\/04\/Chloroquine.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"508\" \/>\n\t<meta property=\"og:image:height\" content=\"312\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Pierre Berecz\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"Pierre Berecz\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/ebrand.com\\\/fr\\\/blog\\\/covid-19-la-contrefacon-cible-les-produits-pharmaceutiques\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/ebrand.com\\\/fr\\\/blog\\\/covid-19-la-contrefacon-cible-les-produits-pharmaceutiques\\\/\"},\"author\":{\"name\":\"Pierre Berecz\",\"@id\":\"https:\\\/\\\/ebrand.com\\\/fr\\\/#\\\/schema\\\/person\\\/5135b414744106b1e8a8e81096553578\"},\"headline\":\"L\u2019IMPACT DU COVID-19 : LA CONTREFA\u00c7ON\",\"datePublished\":\"2020-04-07T15:04:58+00:00\",\"dateModified\":\"2025-04-28T13:12:55+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/ebrand.com\\\/fr\\\/blog\\\/covid-19-la-contrefacon-cible-les-produits-pharmaceutiques\\\/\"},\"wordCount\":837,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/ebrand.com\\\/fr\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/ebrand.com\\\/fr\\\/blog\\\/covid-19-la-contrefacon-cible-les-produits-pharmaceutiques\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/ebrand.com\\\/wp-content\\\/uploads\\\/2020\\\/04\\\/Chloroquine.jpg\",\"articleSection\":[\"Contrefa\u00e7on\",\"Places de march\u00e9\"],\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/ebrand.com\\\/fr\\\/blog\\\/covid-19-la-contrefacon-cible-les-produits-pharmaceutiques\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/ebrand.com\\\/fr\\\/blog\\\/covid-19-la-contrefacon-cible-les-produits-pharmaceutiques\\\/\",\"url\":\"https:\\\/\\\/ebrand.com\\\/fr\\\/blog\\\/covid-19-la-contrefacon-cible-les-produits-pharmaceutiques\\\/\",\"name\":\"L\u2019IMPACT DU COVID-19 : LA CONTREFA\u00c7ON - EBRAND\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/ebrand.com\\\/fr\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/ebrand.com\\\/fr\\\/blog\\\/covid-19-la-contrefacon-cible-les-produits-pharmaceutiques\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/ebrand.com\\\/fr\\\/blog\\\/covid-19-la-contrefacon-cible-les-produits-pharmaceutiques\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/ebrand.com\\\/wp-content\\\/uploads\\\/2020\\\/04\\\/Chloroquine.jpg\",\"datePublished\":\"2020-04-07T15:04:58+00:00\",\"dateModified\":\"2025-04-28T13:12:55+00:00\",\"description\":\"Explorez comment les pirates profitent du Covid-19 pour diffuser des produits pharmaceutiques contrefaits, selon l'OCDE et l'EUIPO.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/ebrand.com\\\/fr\\\/blog\\\/covid-19-la-contrefacon-cible-les-produits-pharmaceutiques\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/ebrand.com\\\/fr\\\/blog\\\/covid-19-la-contrefacon-cible-les-produits-pharmaceutiques\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/ebrand.com\\\/fr\\\/blog\\\/covid-19-la-contrefacon-cible-les-produits-pharmaceutiques\\\/#primaryimage\",\"url\":\"https:\\\/\\\/ebrand.com\\\/wp-content\\\/uploads\\\/2020\\\/04\\\/Chloroquine.jpg\",\"contentUrl\":\"https:\\\/\\\/ebrand.com\\\/wp-content\\\/uploads\\\/2020\\\/04\\\/Chloroquine.jpg\",\"width\":508,\"height\":312,\"caption\":\"Screenshot\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/ebrand.com\\\/fr\\\/blog\\\/covid-19-la-contrefacon-cible-les-produits-pharmaceutiques\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/ebrand.com\\\/fr\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"L\u2019IMPACT DU COVID-19 : LA CONTREFA\u00c7ON\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/ebrand.com\\\/fr\\\/#website\",\"url\":\"https:\\\/\\\/ebrand.com\\\/fr\\\/\",\"name\":\"EBRAND\",\"description\":\"Boost and protect your brands. Mitigate risks, Optimize revenues.\",\"publisher\":{\"@id\":\"https:\\\/\\\/ebrand.com\\\/fr\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/ebrand.com\\\/fr\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/ebrand.com\\\/fr\\\/#organization\",\"name\":\"EBRAND\",\"url\":\"https:\\\/\\\/ebrand.com\\\/fr\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/ebrand.com\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/ebrand.com\\\/wp-content\\\/uploads\\\/2024\\\/07\\\/EBRAND-logo.png\",\"contentUrl\":\"https:\\\/\\\/ebrand.com\\\/wp-content\\\/uploads\\\/2024\\\/07\\\/EBRAND-logo.png\",\"width\":1134,\"height\":1027,\"caption\":\"EBRAND\"},\"image\":{\"@id\":\"https:\\\/\\\/ebrand.com\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.linkedin.com\\\/company\\\/204986\\\/\"],\"description\":\"EBRAND provides expert technical guidance, strategic consultancy, and tailored software solutions for Online Brand Protection, Digital Risk Protection, and Corporate Domain Management,\",\"email\":\"contact@ebrand.com\",\"telephone\":\"+352 20 20 31 00\",\"legalName\":\"EBRAND Holdings S.A.\",\"foundingDate\":\"2007-01-01\",\"vatID\":\"LU22551072\",\"numberOfEmployees\":{\"@type\":\"QuantitativeValue\",\"minValue\":\"201\",\"maxValue\":\"500\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/ebrand.com\\\/fr\\\/#\\\/schema\\\/person\\\/5135b414744106b1e8a8e81096553578\",\"name\":\"Pierre Berecz\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/74380780b68bdee69ccf6d523f22d858ab3a00236aa8b28e1e559c01aca56798?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/74380780b68bdee69ccf6d523f22d858ab3a00236aa8b28e1e559c01aca56798?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/74380780b68bdee69ccf6d523f22d858ab3a00236aa8b28e1e559c01aca56798?s=96&d=mm&r=g\",\"caption\":\"Pierre Berecz\"},\"description\":\"D\u00e9couvrez les articles de Pierre Berecz, pr\u00e9sident d'EBRAND France, sur la protection des marques et les risques num\u00e9riques\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"L\u2019IMPACT DU COVID-19 : LA CONTREFA\u00c7ON - EBRAND","description":"Explorez comment les pirates profitent du Covid-19 pour diffuser des produits pharmaceutiques contrefaits, selon l'OCDE et l'EUIPO.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ebrand.com\/fr\/blog\/covid-19-la-contrefacon-cible-les-produits-pharmaceutiques\/","og_locale":"fr_FR","og_type":"article","og_title":"L\u2019IMPACT DU COVID-19 : LA CONTREFA\u00c7ON","og_description":"Explorez comment les pirates profitent du Covid-19 pour diffuser des produits pharmaceutiques contrefaits, selon l'OCDE et l'EUIPO.","og_url":"https:\/\/ebrand.com\/fr\/blog\/covid-19-la-contrefacon-cible-les-produits-pharmaceutiques\/","og_site_name":"EBRAND","article_published_time":"2020-04-07T15:04:58+00:00","article_modified_time":"2025-04-28T13:12:55+00:00","og_image":[{"width":508,"height":312,"url":"https:\/\/ebrand.com\/wp-content\/uploads\/2020\/04\/Chloroquine.jpg","type":"image\/jpeg"}],"author":"Pierre Berecz","twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"Pierre Berecz","Dur\u00e9e de lecture estim\u00e9e":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/ebrand.com\/fr\/blog\/covid-19-la-contrefacon-cible-les-produits-pharmaceutiques\/#article","isPartOf":{"@id":"https:\/\/ebrand.com\/fr\/blog\/covid-19-la-contrefacon-cible-les-produits-pharmaceutiques\/"},"author":{"name":"Pierre Berecz","@id":"https:\/\/ebrand.com\/fr\/#\/schema\/person\/5135b414744106b1e8a8e81096553578"},"headline":"L\u2019IMPACT DU COVID-19 : LA CONTREFA\u00c7ON","datePublished":"2020-04-07T15:04:58+00:00","dateModified":"2025-04-28T13:12:55+00:00","mainEntityOfPage":{"@id":"https:\/\/ebrand.com\/fr\/blog\/covid-19-la-contrefacon-cible-les-produits-pharmaceutiques\/"},"wordCount":837,"commentCount":0,"publisher":{"@id":"https:\/\/ebrand.com\/fr\/#organization"},"image":{"@id":"https:\/\/ebrand.com\/fr\/blog\/covid-19-la-contrefacon-cible-les-produits-pharmaceutiques\/#primaryimage"},"thumbnailUrl":"https:\/\/ebrand.com\/wp-content\/uploads\/2020\/04\/Chloroquine.jpg","articleSection":["Contrefa\u00e7on","Places de march\u00e9"],"inLanguage":"fr-FR","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/ebrand.com\/fr\/blog\/covid-19-la-contrefacon-cible-les-produits-pharmaceutiques\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/ebrand.com\/fr\/blog\/covid-19-la-contrefacon-cible-les-produits-pharmaceutiques\/","url":"https:\/\/ebrand.com\/fr\/blog\/covid-19-la-contrefacon-cible-les-produits-pharmaceutiques\/","name":"L\u2019IMPACT DU COVID-19 : LA CONTREFA\u00c7ON - EBRAND","isPartOf":{"@id":"https:\/\/ebrand.com\/fr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/ebrand.com\/fr\/blog\/covid-19-la-contrefacon-cible-les-produits-pharmaceutiques\/#primaryimage"},"image":{"@id":"https:\/\/ebrand.com\/fr\/blog\/covid-19-la-contrefacon-cible-les-produits-pharmaceutiques\/#primaryimage"},"thumbnailUrl":"https:\/\/ebrand.com\/wp-content\/uploads\/2020\/04\/Chloroquine.jpg","datePublished":"2020-04-07T15:04:58+00:00","dateModified":"2025-04-28T13:12:55+00:00","description":"Explorez comment les pirates profitent du Covid-19 pour diffuser des produits pharmaceutiques contrefaits, selon l'OCDE et l'EUIPO.","breadcrumb":{"@id":"https:\/\/ebrand.com\/fr\/blog\/covid-19-la-contrefacon-cible-les-produits-pharmaceutiques\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ebrand.com\/fr\/blog\/covid-19-la-contrefacon-cible-les-produits-pharmaceutiques\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/ebrand.com\/fr\/blog\/covid-19-la-contrefacon-cible-les-produits-pharmaceutiques\/#primaryimage","url":"https:\/\/ebrand.com\/wp-content\/uploads\/2020\/04\/Chloroquine.jpg","contentUrl":"https:\/\/ebrand.com\/wp-content\/uploads\/2020\/04\/Chloroquine.jpg","width":508,"height":312,"caption":"Screenshot"},{"@type":"BreadcrumbList","@id":"https:\/\/ebrand.com\/fr\/blog\/covid-19-la-contrefacon-cible-les-produits-pharmaceutiques\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/ebrand.com\/fr\/"},{"@type":"ListItem","position":2,"name":"L\u2019IMPACT DU COVID-19 : LA CONTREFA\u00c7ON"}]},{"@type":"WebSite","@id":"https:\/\/ebrand.com\/fr\/#website","url":"https:\/\/ebrand.com\/fr\/","name":"EBRAND","description":"Boost and protect your brands. Mitigate risks, Optimize revenues.","publisher":{"@id":"https:\/\/ebrand.com\/fr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/ebrand.com\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/ebrand.com\/fr\/#organization","name":"EBRAND","url":"https:\/\/ebrand.com\/fr\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/ebrand.com\/fr\/#\/schema\/logo\/image\/","url":"https:\/\/ebrand.com\/wp-content\/uploads\/2024\/07\/EBRAND-logo.png","contentUrl":"https:\/\/ebrand.com\/wp-content\/uploads\/2024\/07\/EBRAND-logo.png","width":1134,"height":1027,"caption":"EBRAND"},"image":{"@id":"https:\/\/ebrand.com\/fr\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.linkedin.com\/company\/204986\/"],"description":"EBRAND provides expert technical guidance, strategic consultancy, and tailored software solutions for Online Brand Protection, Digital Risk Protection, and Corporate Domain Management,","email":"contact@ebrand.com","telephone":"+352 20 20 31 00","legalName":"EBRAND Holdings S.A.","foundingDate":"2007-01-01","vatID":"LU22551072","numberOfEmployees":{"@type":"QuantitativeValue","minValue":"201","maxValue":"500"}},{"@type":"Person","@id":"https:\/\/ebrand.com\/fr\/#\/schema\/person\/5135b414744106b1e8a8e81096553578","name":"Pierre Berecz","image":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/secure.gravatar.com\/avatar\/74380780b68bdee69ccf6d523f22d858ab3a00236aa8b28e1e559c01aca56798?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/74380780b68bdee69ccf6d523f22d858ab3a00236aa8b28e1e559c01aca56798?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/74380780b68bdee69ccf6d523f22d858ab3a00236aa8b28e1e559c01aca56798?s=96&d=mm&r=g","caption":"Pierre Berecz"},"description":"D\u00e9couvrez les articles de Pierre Berecz, pr\u00e9sident d'EBRAND France, sur la protection des marques et les risques num\u00e9riques"}]}},"_links":{"self":[{"href":"https:\/\/ebrand.com\/fr\/wp-json\/wp\/v2\/posts\/13409","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ebrand.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ebrand.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ebrand.com\/fr\/wp-json\/wp\/v2\/users\/8"}],"replies":[{"embeddable":true,"href":"https:\/\/ebrand.com\/fr\/wp-json\/wp\/v2\/comments?post=13409"}],"version-history":[{"count":2,"href":"https:\/\/ebrand.com\/fr\/wp-json\/wp\/v2\/posts\/13409\/revisions"}],"predecessor-version":[{"id":46368,"href":"https:\/\/ebrand.com\/fr\/wp-json\/wp\/v2\/posts\/13409\/revisions\/46368"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ebrand.com\/fr\/wp-json\/wp\/v2\/media\/42719"}],"wp:attachment":[{"href":"https:\/\/ebrand.com\/fr\/wp-json\/wp\/v2\/media?parent=13409"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ebrand.com\/fr\/wp-json\/wp\/v2\/categories?post=13409"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ebrand.com\/fr\/wp-json\/wp\/v2\/tags?post=13409"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}